CLINICAL_TRIALS
trial_result
· 2011-06-10
Clinical Trial Update: TLESR-impedance Study in Patients [Phase 2]
Summary
Phase 2 trial results update for a TLESR-impedance study in patients with gastroesophageal reflux disease.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: AstraZeneca | Conditions: Reflux Episodes | Phase 2 | Status: COMPLETED | Results posted: 2011-06-10